Mumbai: Alkem Labs has announced the appointment of Sanjay Kumar Dipak at senior management position in the Company effective from 28th February, 2025.
Sanjay Kumar Dipak has completed his Executive Business Management from Indian Institute of Management, Kolkata. He brings with him over 28 years of extensive experience in pharmaceutical industry and has an expertise in creating, communicating vision & strategy that supports business & employee engagement.
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, Ophthalmology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
